News
Two and a half years into his tenure as Teva’s CEO, Richard Francis is breaking down the strategy that’s powered the company through nine consecutive quarters of growth. On this week’s ...
Goldman Sachs analysts began coverage of Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy rating and a price target of $24, on June 6.
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on TEVA.
About Teva Pharmaceutical Indus Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world.
Teva Pharmaceutical Industries Ltd. announced the final analysis of the PEARL Phase 4 study at the European Academy of Neurology Congress 2025, confirming that AJOVY (fremanezumab) is effective in ...
Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid crisis in the US for up to $4.25 billion, including already ...
EU fines Teva €462.5m for artificially extending the patent protection for former multiple sclerosis blockbuster Copaxone.
BYU quarterback Jake Retzlaff denied sexual assault allegations from a 2023 encounter after a woman filed a lawsuit in Utah last month.
Walmart has agreed to pay $10 million to settle allegations by the FTC that it allowed scammers to exploit its in-store money transfer services.
Lawyers for BYU quarterback Jake Retzlaff deny a woman's allegations of sexual assault in response to a lawsuit in May 2025.
Months after Paramount reportedly began talks to settle President Trump’s false-advertising claim against CBS, the company is still holding fast. “This is a meritless lawsuit,” begins its ...
Kristin Cavallari opens up to PEOPLE about the allegations of drug use she faced on 'The Hills' season 6 and the regrets she has about how she handled them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results